Cargando…
A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure
Currently, the early introduction of new antiandrogens is popular for castration-resistant prostate cancer (CRPC). However, adverse events can be severe and their costs are high. Here, we present a patient with CRPC in whom flutamide controlled disease progression for 10 years. This case report show...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nagoya University
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892669/ https://www.ncbi.nlm.nih.gov/pubmed/31849389 http://dx.doi.org/10.18999/nagjms.81.4.707 |
_version_ | 1783476064158220288 |
---|---|
author | Muramatsu, Tomoaki Funahashi, Yasuhito Yamamoto, Akiyuki Sassa, Naoto Matsukawa, Yoshihisa Gotoh, Momokazu |
author_facet | Muramatsu, Tomoaki Funahashi, Yasuhito Yamamoto, Akiyuki Sassa, Naoto Matsukawa, Yoshihisa Gotoh, Momokazu |
author_sort | Muramatsu, Tomoaki |
collection | PubMed |
description | Currently, the early introduction of new antiandrogens is popular for castration-resistant prostate cancer (CRPC). However, adverse events can be severe and their costs are high. Here, we present a patient with CRPC in whom flutamide controlled disease progression for 10 years. This case report shows that conventional alternative antiandrogens are cost effective and are still an important option for the treatment for CRPC. |
format | Online Article Text |
id | pubmed-6892669 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nagoya University |
record_format | MEDLINE/PubMed |
spelling | pubmed-68926692019-12-17 A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure Muramatsu, Tomoaki Funahashi, Yasuhito Yamamoto, Akiyuki Sassa, Naoto Matsukawa, Yoshihisa Gotoh, Momokazu Nagoya J Med Sci Case Report Currently, the early introduction of new antiandrogens is popular for castration-resistant prostate cancer (CRPC). However, adverse events can be severe and their costs are high. Here, we present a patient with CRPC in whom flutamide controlled disease progression for 10 years. This case report shows that conventional alternative antiandrogens are cost effective and are still an important option for the treatment for CRPC. Nagoya University 2019-11 /pmc/articles/PMC6892669/ /pubmed/31849389 http://dx.doi.org/10.18999/nagjms.81.4.707 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Muramatsu, Tomoaki Funahashi, Yasuhito Yamamoto, Akiyuki Sassa, Naoto Matsukawa, Yoshihisa Gotoh, Momokazu A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure |
title | A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure |
title_full | A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure |
title_fullStr | A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure |
title_full_unstemmed | A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure |
title_short | A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure |
title_sort | case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892669/ https://www.ncbi.nlm.nih.gov/pubmed/31849389 http://dx.doi.org/10.18999/nagjms.81.4.707 |
work_keys_str_mv | AT muramatsutomoaki acaseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure AT funahashiyasuhito acaseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure AT yamamotoakiyuki acaseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure AT sassanaoto acaseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure AT matsukawayoshihisa acaseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure AT gotohmomokazu acaseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure AT muramatsutomoaki caseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure AT funahashiyasuhito caseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure AT yamamotoakiyuki caseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure AT sassanaoto caseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure AT matsukawayoshihisa caseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure AT gotohmomokazu caseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure |